BlackRock Advisors’s Apyx Medical APYX Stock Holding History

BlackRock Advisors’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$17K	Hold	4,719	–	–	﹤0.01%	3486
2016 Q3	$25K	Sell	4,719 -2,924	-38%	-$9.48K	﹤0.01%	3399
2016 Q2	$13K	Hold	7,643	–	–	﹤0.01%	3528
2016 Q1	$13K	Hold	7,643	–	–	﹤0.01%	3525
2015 Q4	$16K	Hold	7,643	–	–	﹤0.01%	3541
2015 Q3	$15K	Hold	7,643	–	–	﹤0.01%	3575
2015 Q2	$21K	Buy	7,643 +1,719	+29%	+$4.73K	﹤0.01%	3494
2015 Q1	$14K	Hold	5,924	–	–	﹤0.01%	3496
2014 Q4	$22K	Hold	5,924	–	–	﹤0.01%	3481
2014 Q3	$24K	Hold	5,924	–	–	﹤0.01%	3463
2014 Q2	$22K	Hold	5,924	–	–	﹤0.01%	3422
2014 Q1	$23K	Buy	5,924 +2,598	+78%	+$7.65K	﹤0.01%	3382
2013 Q4	$7K	Hold	3,326	–	–	﹤0.01%	3546
2013 Q3	$9K	Hold	3,326	–	–	﹤0.01%	3472
2013 Q2	$10K	Buy	+3,326	New	+$11.2K	﹤0.01%	3407

Other funds holding APYX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock Advisors's APYX Position: Q4 2016 in Review

BlackRock Advisors held its Apyx Medical (APYX) position steady in Q4 2016 at 4,719 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #3486.

BlackRock Advisors first reported a position in APYX in Q2 2013 and has held it in 15 quarters since. The position peaked at $25K in Q3 2016. 39 funds tracked by Wall St. Rank hold APYX as of Q4 2016.

BlackRock Advisors held 4,719 shares of Apyx Medical worth $17K as of Q4 2016.
BlackRock Advisors left its Apyx Medical share count unchanged in Q4 2016.
Apyx Medical made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3486 holding.
BlackRock Advisors first reported a position in Apyx Medical in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Apyx Medical position peaked at $25K in Q3 2016.
39 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.